← Back to Search

Intraocular Lens

Phacoemulsification surgery for Cataract

N/A
Waitlist Available
Research Sponsored by Alcon Research
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up month 3 postoperative visit
Awards & highlights

Study Summary

This trial will compare two types of intraocular lenses (IOLs) to see which results in better distance vision 3 months after surgery.

Eligible Conditions
  • Cataract
  • Aphakia

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~month 3 postoperative visit
This trial's timeline: 3 weeks for screening, Varies for treatment, and month 3 postoperative visit for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Mean binocular best-corrected distance visual acuity (BCDVA) at 4 meters

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Clareon/Clareon ToricExperimental Treatment3 Interventions
Phacoemulsification surgery, followed by implantation with Alcon Clareon Aspheric Hydrophobic Acrylic IOL or Alcon Clareon Aspheric Hydrophobic Acrylic Toric IOL, as indicated. The second eye surgery is recommended to occur within 14 days after the 1st eye surgery.
Group II: Eyhance/Eyhance ToricActive Control3 Interventions
Phacoemulsification surgery, followed by implantation with TECNIS Eyhance IOL or TECNIS Eyhance Toric II IOL, as indicated. The second eye surgery is recommended to occur within 14 days after the 1st eye surgery.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Clareon IOL
2022
N/A
~190
Clareon Toric IOL
2022
N/A
~190
Phacoemulsification surgery
2013
N/A
~250

Find a Location

Who is running the clinical trial?

Alcon ResearchLead Sponsor
703 Previous Clinical Trials
124,289 Total Patients Enrolled
116 Trials studying Cataract
20,550 Patients Enrolled for Cataract
Clinical Trial Lead, CDMA SurgicalStudy DirectorAlcon Research, LLC

Media Library

Clareon Toric IOL (Intraocular Lens) Clinical Trial Eligibility Overview. Trial Name: NCT05481125 — N/A
Cataract Research Study Groups: Clareon/Clareon Toric, Eyhance/Eyhance Toric
Cataract Clinical Trial 2023: Clareon Toric IOL Highlights & Side Effects. Trial Name: NCT05481125 — N/A
Clareon Toric IOL (Intraocular Lens) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05481125 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the enrollment quota for this clinical research?

"For this medical trial to be successful, 185 eligible patients need to partake in the experiment. These individuals can visit two of the sites involved with this study: Alcon Investigator 3828 based in Poughkeepsie, New york and Alcon Investigator 5848 located in Houston, Texas."

Answered by AI

Are there currently spots available for participants in this trial?

"Affirmative. The information accessible on clinicaltrials.gov demonstrates that this research is actively enrolling participants - the trial was originally shared on 10/10/2022 and most recently updated in October 17th 2022, with 185 people needed to be recruited from 8 distinct sites."

Answered by AI

What number of healthcare facilities are presently facilitating this trial?

"Patients are being accepted at Alcon Investigator 3828 located in Poughkeepsie, New york; furthermore, the trial is recruiting from 8 other centres including Houston's Alcon Investigator 5848 and Salt Lake City's Alcon Investigator 8025."

Answered by AI

Who else is applying?

What state do they live in?
Florida
What site did they apply to?
Alcon Investigator 1007
What portion of applicants met pre-screening criteria?
Met criteria
Recent research and studies
clinicaltrials.govStudy
Clareon Toric vs Eyhance Toric
2022. "Clareon Toric vs Eyhance Toric". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05481125.
~73 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top